S15-240 Controlling AAV receptor expression to improve testing and validation of AAV gene therapy products Adeno-associated virus (AAV) vectored products are currently leading candidates for gene therapy applications with multiple approved products and many more in clinical trials. Sirika Wood Jan Carette Michael Chapman Nancy Meyer Andreas Puschnik Omar Davulcu